• #24: US Pharma and Life Sciences Deals: 2025

  • 2025/02/19
  • 再生時間： 13 分
  • ポッドキャスト

#24: US Pharma and Life Sciences Deals: 2025

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • The pharmaceutical and life sciences sector anticipates a surge in merger and acquisition activity in 2025. Driving this trend are expected interest rate reductions by the Federal Reserve and the resolution of post-election uncertainties. While deal values and volumes are projected to rise, transactions in the $5 billion to $15 billion range are forecasted to be the most common. However, geopolitical issues could present obstacles to this growth.




    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示

あらすじ・解説

The pharmaceutical and life sciences sector anticipates a surge in merger and acquisition activity in 2025. Driving this trend are expected interest rate reductions by the Federal Reserve and the resolution of post-election uncertainties. While deal values and volumes are projected to rise, transactions in the $5 billion to $15 billion range are forecasted to be the most common. However, geopolitical issues could present obstacles to this growth.




Hosted on Acast. See acast.com/privacy for more information.
続きを読む 一部表示

#24: US Pharma and Life Sciences Deals: 2025に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。